Emerging virus-host cell protein interaction networks
新兴的病毒-宿主细胞蛋白质相互作用网络
基本信息
- 批准号:9063092
- 负责人:
- 金额:$ 73.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-05-04 至 2020-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffinity ChromatographyAgonistAntiviral AgentsArenavirusBenchmarkingBindingBinding ProteinsBiochemicalBioinformaticsBiologicalBiological AssayCategoriesCell CommunicationCell Culture TechniquesCellsComplexContainmentCrimean-Congo Hemorrhagic Fever VirusDataData SetDengue VirusDependenceDevelopmentDisease OutbreaksDisease OutcomeDrug effect disorderEbola virusEnvironmentFamilyFilovirusFrankfurt-Marburg Syndrome VirusGenotypeGoalsHealthHepatitis C virusHumanIndividualInfectionInformaticsJunin virusLaboratoriesLassa FeverLassa fever virusLeadLifeLife Cycle StagesLocationMapsMass Spectrum AnalysisMethodsModelingMolecularMusNational Institute of Allergy and Infectious DiseaseNational SecurityOrthobunyavirusPathogenesisPathway interactionsPreparationPrincipal InvestigatorProteinsRNA InterferenceRNA VirusesRecruitment ActivityReportingResearchRiskRoleSignal PathwayTechniquesTechnologyTestingTissuesViral Hemorrhagic FeversViral ProteinsVirusVirus DiseasesVirus ReplicationWorkYeastscellular targetingcofactorexperiencegammaherpesvirusgenome-widehemorrhagic fever virusimprovedinsightinterestmortalitynetwork modelsnovel strategiespathogenprogramsprotein protein interactionscreeningsmall moleculesmall molecule inhibitorvirus host interactionyeast two hybrid system
项目摘要
DESCRIPTION (provided by applicant): The overall goal of this proposal is to identify and characterize cellular proteins that bind to viral hemorrhagic fever viruses. Specifically, we focus
on RNA viruses from four families: the filoviruses Ebolavirus and Marburg virus; the Arenaviruses Junin virus and Lassa Fever virus; and the Bunyavirus Crimean-Congo hemorrhagic fever virus. These emerging viruses pose significant risks to human health and national security. While each differs in the types of proteins encoded, they share similar disease outcomes, causing severe, often fatal infections in humans; all are classified as NIAID Category A Priority Pathogens. Due to the high level containment needed to work with many of them, there is a significant gap in our understanding of these viruses and no specific, approved therapies are currently available. Like all viruses, these emerging viruses rely on host cell proteins in order to replicate. This dependence represents a potential "Achilles heel" in the virus
life cycle that may be exploited to develop new approaches to treat viral infections. However, only a small number of virus-host cell protein interactions have been reported for the viruses in this study, and no systematic analysis of emerging virus-host cell protein interactions has been performed. In this project we develop and evaluate high quality maps of emerging virus-human protein interactions. In Aim 1 we use complementary yeast two-hybrid screening and co-affinity purification plus mass spectrometry approaches to identify cellular proteins that bind to emerging viruses and closely related non-pathogenic viruses from the same family. In aim 2 we identify shared and virus-specific features of the host cell interaction networks of emerging viruses. We use orthologonal protein-protein interaction assays to identify shared and virus specific interactions within each virus family. To gain confidence in these results, each assay is benchmarked against the human positive and random reference sets. We then employ informatic approaches to discover pathways that targeted preferentially by emerging viruses, develop tissue-specific virus-host cell protein interaction networks, and identify small molecule agonists or antagonists predicted to inhibit virus replication. In aim 3, we test the predictions generated through the bioinformatic analyses. A subset of high-interest cellular proteins targeted by multiple viruses will be experimentally interrogated for their contribution to infectio using RNA interference. State-of-the-art molecular techniques are then employed to determine the mechanisms by which they contribute to virus replication. Virus- and tissue-specific interactions are evaluated for their contribution to virus replication and their effect on cellular
signaling pathways. Finally, small molecule inhibitors identified in our network models are evaluated for their effect on virus replication in cell culture. The data generated from this projet will improve our understanding of the functions of individual viral proteins, provide insight into the overall strategies used by viral hemorrhagic fever virus to interface with their host cells, an may lead to the discovery of new targets for treatments of emerging viruses.
描述(由申请方提供):本提案的总体目标是鉴定和表征与病毒性出血热病毒结合的细胞蛋白。具体来说,我们专注于
对来自四个科的RNA病毒:丝状病毒埃博拉病毒和马尔堡病毒;沙粒病毒朱宁病毒和拉沙热病毒;以及布尼亚病毒克里米亚-刚果出血热病毒。这些新出现的病毒对人类健康和国家安全构成重大风险。虽然每种编码的蛋白质类型不同,但它们具有相似的疾病结果,导致严重的,通常是致命的人类感染;所有这些都被归类为NIAID A类优先病原体。由于需要对其中许多病毒进行高水平的遏制,我们对这些病毒的理解存在重大差距,目前没有具体的批准治疗方法。像所有病毒一样,这些新兴病毒依赖于宿主细胞蛋白来复制。这种依赖性代表了病毒的一个潜在的“致命弱点”
生命周期,可以利用开发新的方法来治疗病毒感染。然而,本研究中仅报告了少量病毒-宿主细胞蛋白相互作用,未对新出现的病毒-宿主细胞蛋白相互作用进行系统分析。在这个项目中,我们开发和评估新出现的病毒-人类蛋白质相互作用的高质量图谱。在目标1中,我们使用互补酵母双杂交筛选和共亲和纯化加质谱法来鉴定与来自同一家族的新出现的病毒和密切相关的非致病性病毒结合的细胞蛋白。在目标2中,我们确定了新兴病毒的宿主细胞相互作用网络的共享和病毒特异性特征。我们使用直向同源蛋白质-蛋白质相互作用测定来鉴定每个病毒家族内的共享和病毒特异性相互作用。为了获得这些结果的置信度,将每个检测试剂盒与人阳性和随机参考集进行基准比较。然后,我们采用信息学方法来发现新兴病毒优先靶向的途径,开发组织特异性病毒-宿主细胞蛋白相互作用网络,并确定预测抑制病毒复制的小分子激动剂或拮抗剂。在目标3中,我们测试了通过生物信息学分析产生的预测。一个由多种病毒靶向的高兴趣细胞蛋白的子集将被实验性地询问它们对使用RNA干扰的感染的贡献。然后采用最先进的分子技术来确定它们促进病毒复制的机制。评价病毒和组织特异性相互作用对病毒复制的贡献及其对细胞增殖的影响。
信号通路最后,在我们的网络模型中鉴定的小分子抑制剂被评估其对细胞培养物中的病毒复制的影响。该项目产生的数据将提高我们对单个病毒蛋白功能的理解,深入了解病毒性出血热病毒与其宿主细胞相互作用的总体策略,并可能导致发现治疗新兴病毒的新靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT A DAVEY其他文献
ROBERT A DAVEY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT A DAVEY', 18)}}的其他基金
Antiviral Lead Identification to Treat Filovirus Infections
治疗丝状病毒感染的抗病毒先导药物鉴定
- 批准号:
10453443 - 财政年份:2019
- 资助金额:
$ 73.49万 - 项目类别:
Antiviral Lead Identification to Treat Filovirus Infections
治疗丝状病毒感染的抗病毒先导药物鉴定
- 批准号:
10217981 - 财政年份:2019
- 资助金额:
$ 73.49万 - 项目类别:
Antiviral Lead Identification to Treat Filovirus Infections
治疗丝状病毒感染的抗病毒先导药物鉴定
- 批准号:
9765787 - 财政年份:2019
- 资助金额:
$ 73.49万 - 项目类别:
High Biocontainment (BSL4/ABSL4) core for replication competent virus work
用于复制病毒工作的高生物防护 (BSL4/ABSL4) 核心
- 批准号:
10555054 - 财政年份:2016
- 资助金额:
$ 73.49万 - 项目类别:
Roles of host factor protein subnetworks in regulating steps of filovirus infection
宿主因子蛋白亚网在丝状病毒感染调节步骤中的作用
- 批准号:
10555057 - 财政年份:2016
- 资助金额:
$ 73.49万 - 项目类别:
Emerging virus-host cell protein interaction networks
新兴的病毒-宿主细胞蛋白质相互作用网络
- 批准号:
8964885 - 财政年份:2015
- 资助金额:
$ 73.49万 - 项目类别:
Novel broad spectrum inhibitors of filovirus infection
丝状病毒感染的新型广谱抑制剂
- 批准号:
8806955 - 财政年份:2015
- 资助金额:
$ 73.49万 - 项目类别:
Novel broad spectrum inhibitors of filovirus infection
丝状病毒感染的新型广谱抑制剂
- 批准号:
9131611 - 财政年份:2015
- 资助金额:
$ 73.49万 - 项目类别:
HTS for Filo- and Arena-virus Entry Mechanisms
用于丝状病毒和沙粒病毒进入机制的 HTS
- 批准号:
7845149 - 财政年份:2009
- 资助金额:
$ 73.49万 - 项目类别:
Discovery & Characterization of Filo-. Arena -and Alpha Virus Entry Inhibitors
发现
- 批准号:
7676506 - 财政年份:2009
- 资助金额:
$ 73.49万 - 项目类别:
相似海外基金
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10506915 - 财政年份:2021
- 资助金额:
$ 73.49万 - 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10325006 - 财政年份:2021
- 资助金额:
$ 73.49万 - 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
- 批准号:
1746198 - 财政年份:2018
- 资助金额:
$ 73.49万 - 项目类别:
Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
- 批准号:
512537-2017 - 财政年份:2017
- 资助金额:
$ 73.49万 - 项目类别:
University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
- 批准号:
1404605 - 财政年份:2014
- 资助金额:
$ 73.49万 - 项目类别:
Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
- 批准号:
1263713 - 财政年份:2013
- 资助金额:
$ 73.49万 - 项目类别:
Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
- 批准号:
425749-2012 - 财政年份:2012
- 资助金额:
$ 73.49万 - 项目类别:
Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
- 批准号:
1159886 - 财政年份:2012
- 资助金额:
$ 73.49万 - 项目类别:
Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
- 批准号:
19560760 - 财政年份:2007
- 资助金额:
$ 73.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
- 批准号:
234753-2000 - 财政年份:2003
- 资助金额:
$ 73.49万 - 项目类别:
Collaborative Research and Development Grants














{{item.name}}会员




